Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × NETWORK × GastroEsophageal Cancer × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 4 Non-Muscle Invasive Bladder Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Sarcoma, Kaposi 2 Sarcoma, Alveolar Soft Part 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Lymphoma 2 Colonic Neoplasms 2 Clear-cell metastatic renal cell carcinoma 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neurofibrosarcoma 1 Musculoskeletal Pain 1 Malignant Solid Neoplasm 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1

Interventions

bemarituzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06978062 2025-06-05

NeoBEMA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Not yet recruiting

Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡